AQST experienced substantially deteriorating financial performance with net losses roughly doubling alongside meaningful increases in SG&A expenses and operating cash outflows.
The company's financial distress has intensified significantly, with losses expanding substantially while operating cash burn increased meaningfully to over $52M. Despite raising capital (evidenced by higher total assets and outstanding share count increasing from 98.9M to 122M shares), the company's cash position declined and stockholders remain in a substantial deficit position.
AQST shows signs of acute financial stress with net losses expanding substantially while SG&A expenses grew notably, partially offset by modest reductions in R&D spending. The balance sheet reflects recent capital raising activity with total assets increasing meaningfully to $160.4M and share count rising significantly, though cash declined to $31.8M and stockholders' equity remains deeply negative at -$33.7M. Operating cash outflows deteriorated meaningfully, indicating the company continues burning cash at an accelerated rate despite cost reduction efforts.
Net income declined 89.8% — review whether driven by operations, interest costs, or non-recurring items.
Current assets grew 69.2% — improving short-term liquidity or inventory/receivables build.
SG&A up 59.1% — significant increase in sales or administrative costs, monitor impact on operating leverage.
Asset base grew 58.2% — expansion through organic growth, acquisitions, or capital deployment.
Operating cash flow fell 46.6% — earnings quality concerns; investigate working capital changes and non-cash items.
Equity base grew 44% — retained earnings accumulation or equity issuance strengthening the balance sheet.
Cash declined 35.5% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.
Liabilities increased 20.1% — monitor debt-to-equity ratio and interest coverage.
R&D spending cut 15.2% — could signal cost discipline or concerning reduction in innovation investment.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →